

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Golgi transport vesicle coating (GO:0048200) | 6.82695544 |
| 2 | COPI coating of Golgi vesicle (GO:0048205) | 6.82695544 |
| 3 | peptidyl-arginine omega-N-methylation (GO:0035247) | 5.24277185 |
| 4 | NADH metabolic process (GO:0006734) | 5.18974429 |
| 5 | DNA deamination (GO:0045006) | 4.91463820 |
| 6 | peptidyl-arginine methylation (GO:0018216) | 4.61810833 |
| 7 | peptidyl-arginine N-methylation (GO:0035246) | 4.61810833 |
| 8 | proteasome assembly (GO:0043248) | 4.49552700 |
| 9 | oxaloacetate metabolic process (GO:0006107) | 4.46025364 |
| 10 | spliceosomal tri-snRNP complex assembly (GO:0000244) | 4.34445235 |
| 11 | L-phenylalanine metabolic process (GO:0006558) | 4.32227903 |
| 12 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.32227903 |
| 13 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 4.30501260 |
| 14 | proline biosynthetic process (GO:0006561) | 4.27931336 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 4.20386524 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.20386524 |
| 17 | amino acid salvage (GO:0043102) | 4.13691647 |
| 18 | L-methionine salvage (GO:0071267) | 4.13691647 |
| 19 | L-methionine biosynthetic process (GO:0071265) | 4.13691647 |
| 20 | ribosome assembly (GO:0042255) | 4.13058251 |
| 21 | histone arginine methylation (GO:0034969) | 4.09736939 |
| 22 | regulation of mitochondrial translation (GO:0070129) | 4.08085984 |
| 23 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.06974704 |
| 24 | glycine metabolic process (GO:0006544) | 4.04490194 |
| 25 | lysine catabolic process (GO:0006554) | 4.03095709 |
| 26 | lysine metabolic process (GO:0006553) | 4.03095709 |
| 27 | negative regulation of mRNA splicing, via spliceosome (GO:0048025) | 3.96998971 |
| 28 | ADP metabolic process (GO:0046031) | 3.95627420 |
| 29 | detection of calcium ion (GO:0005513) | 3.93788236 |
| 30 | modulation by virus of host process (GO:0019054) | 3.91664123 |
| 31 | protein deneddylation (GO:0000338) | 3.73860153 |
| 32 | * metallo-sulfur cluster assembly (GO:0031163) | 3.73821447 |
| 33 | * iron-sulfur cluster assembly (GO:0016226) | 3.73821447 |
| 34 | regulation of translational fidelity (GO:0006450) | 3.73269571 |
| 35 | cullin deneddylation (GO:0010388) | 3.72707041 |
| 36 | L-methionine biosynthetic process from methylthioadenosine (GO:0019509) | 3.72240150 |
| 37 | establishment of integrated proviral latency (GO:0075713) | 3.67963715 |
| 38 | tricarboxylic acid cycle (GO:0006099) | 3.67825009 |
| 39 | galactose catabolic process (GO:0019388) | 3.63740274 |
| 40 | tricarboxylic acid metabolic process (GO:0072350) | 3.60439438 |
| 41 | serine family amino acid catabolic process (GO:0009071) | 3.57126576 |
| 42 | positive regulation of mitochondrial fission (GO:0090141) | 3.55670365 |
| 43 | aromatic amino acid family catabolic process (GO:0009074) | 3.54378827 |
| 44 | aspartate family amino acid catabolic process (GO:0009068) | 3.54167707 |
| 45 | cysteine metabolic process (GO:0006534) | 3.53265087 |
| 46 | serine family amino acid metabolic process (GO:0009069) | 3.52336340 |
| 47 | succinate metabolic process (GO:0006105) | 3.50640409 |
| 48 | aldehyde catabolic process (GO:0046185) | 3.50124459 |
| 49 | sulfur amino acid catabolic process (GO:0000098) | 3.48333132 |
| 50 | glutathione biosynthetic process (GO:0006750) | 3.48176049 |
| 51 | transcription from mitochondrial promoter (GO:0006390) | 3.47065374 |
| 52 | DNA unwinding involved in DNA replication (GO:0006268) | 3.46877528 |
| 53 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.44714466 |
| 54 | non-recombinational repair (GO:0000726) | 3.44714466 |
| 55 | nucleoside diphosphate biosynthetic process (GO:0009133) | 3.42181975 |
| 56 | serine family amino acid biosynthetic process (GO:0009070) | 3.41022993 |
| 57 | sulfur amino acid biosynthetic process (GO:0000097) | 3.40870088 |
| 58 | oxidative phosphorylation (GO:0006119) | 3.40284505 |
| 59 | protein insertion into membrane (GO:0051205) | 3.40280582 |
| 60 | glyoxylate metabolic process (GO:0046487) | 3.34780026 |
| 61 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.33566782 |
| 62 | ATP synthesis coupled proton transport (GO:0015986) | 3.33526310 |
| 63 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.33526310 |
| 64 | DNA strand elongation (GO:0022616) | 3.33434766 |
| 65 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.32398903 |
| 66 | phosphorelay signal transduction system (GO:0000160) | 3.31997254 |
| 67 | viral mRNA export from host cell nucleus (GO:0046784) | 3.30576430 |
| 68 | negative regulation of mRNA processing (GO:0050686) | 3.30217645 |
| 69 | respiratory electron transport chain (GO:0022904) | 3.29414575 |
| 70 | protein retention in ER lumen (GO:0006621) | 3.29029399 |
| 71 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.28834126 |
| 72 | purine nucleobase biosynthetic process (GO:0009113) | 3.27385315 |
| 73 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 3.27024448 |
| 74 | termination of RNA polymerase III transcription (GO:0006386) | 3.27024448 |
| 75 | chaperone-mediated protein transport (GO:0072321) | 3.27009761 |
| 76 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.26468957 |
| 77 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 3.26137190 |
| 78 | 2-oxoglutarate metabolic process (GO:0006103) | 3.26010870 |
| 79 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.25317137 |
| 80 | folic acid metabolic process (GO:0046655) | 3.24470357 |
| 81 | protein maturation by protein folding (GO:0022417) | 3.24074642 |
| 82 | neuromuscular process controlling posture (GO:0050884) | 3.23209336 |
| 83 | methionine metabolic process (GO:0006555) | 3.22658534 |
| 84 | snRNA processing (GO:0016180) | 3.20583093 |
| 85 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.20282480 |
| 86 | electron transport chain (GO:0022900) | 3.20149623 |
| 87 | nuclear envelope reassembly (GO:0031468) | 3.18397789 |
| 88 | mitotic nuclear envelope reassembly (GO:0007084) | 3.18397789 |
| 89 | kynurenine metabolic process (GO:0070189) | 3.16677317 |
| 90 | peptidyl-histidine modification (GO:0018202) | 3.16403108 |
| 91 | snRNA metabolic process (GO:0016073) | 3.15430952 |
| 92 | methionine biosynthetic process (GO:0009086) | 3.15216088 |
| 93 | ribosome biogenesis (GO:0042254) | 3.14904973 |
| 94 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 3.14176232 |
| 95 | nonribosomal peptide biosynthetic process (GO:0019184) | 3.13732053 |
| 96 | dosage compensation (GO:0007549) | 3.11154860 |
| 97 | regulation of translational termination (GO:0006449) | 3.10280294 |
| 98 | aspartate family amino acid metabolic process (GO:0009066) | 3.09624449 |
| 99 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 3.08951693 |
| 100 | aspartate family amino acid biosynthetic process (GO:0009067) | 3.07932239 |
| 101 | amino-acid betaine metabolic process (GO:0006577) | 3.07373921 |
| 102 | proline metabolic process (GO:0006560) | 3.06781544 |
| 103 | mitochondrial fusion (GO:0008053) | 3.05027722 |
| 104 | indole-containing compound catabolic process (GO:0042436) | 3.03329168 |
| 105 | indolalkylamine catabolic process (GO:0046218) | 3.03329168 |
| 106 | tryptophan catabolic process (GO:0006569) | 3.03329168 |
| 107 | tRNA aminoacylation for protein translation (GO:0006418) | 3.02310027 |
| 108 | protoporphyrinogen IX metabolic process (GO:0046501) | 3.02024416 |
| 109 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.01038510 |
| 110 | mitochondrial fragmentation involved in apoptotic process (GO:0043653) | 3.00814524 |
| 111 | S-adenosylmethionine metabolic process (GO:0046500) | 3.00803946 |
| 112 | endothelial tube morphogenesis (GO:0061154) | 3.00800993 |
| 113 | morphogenesis of an endothelium (GO:0003159) | 3.00800993 |
| 114 | regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315) | 3.00367414 |
| 115 | glycolytic process (GO:0006096) | 3.00131199 |
| 116 | NAD metabolic process (GO:0019674) | 2.99279065 |
| 117 | sulfur amino acid metabolic process (GO:0000096) | 2.98183870 |
| 118 | alpha-amino acid catabolic process (GO:1901606) | 2.97741575 |
| 119 | GDP-mannose metabolic process (GO:0019673) | 2.97730967 |
| 120 | positive regulation of synapse maturation (GO:0090129) | 2.97306861 |
| 121 | establishment of viral latency (GO:0019043) | 2.94927386 |
| 122 | negative regulation of mRNA metabolic process (GO:1903312) | 2.93957832 |
| 123 | nucleobase biosynthetic process (GO:0046112) | 2.93291190 |
| 124 | cellular amino acid catabolic process (GO:0009063) | 2.92608479 |
| 125 | mitochondrial RNA metabolic process (GO:0000959) | 2.92373935 |
| 126 | tRNA aminoacylation (GO:0043039) | 2.91938340 |
| 127 | amino acid activation (GO:0043038) | 2.91938340 |
| 128 | glutamate metabolic process (GO:0006536) | 2.91763010 |
| 129 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.90183617 |
| 130 | establishment of protein localization to mitochondrion (GO:0072655) | 2.90082875 |
| 131 | spliceosomal snRNP assembly (GO:0000387) | 2.88633862 |
| 132 | L-serine metabolic process (GO:0006563) | 2.87411148 |
| 133 | regulation of cofactor metabolic process (GO:0051193) | 2.86750155 |
| 134 | regulation of coenzyme metabolic process (GO:0051196) | 2.86750155 |
| 135 | bile acid biosynthetic process (GO:0006699) | 2.86475191 |
| 136 | aromatic amino acid family metabolic process (GO:0009072) | 2.86457810 |
| 137 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.84957809 |
| 138 | acetyl-CoA metabolic process (GO:0006084) | 2.83862023 |
| 139 | heme transport (GO:0015886) | 2.83699960 |
| 140 | cellular modified amino acid catabolic process (GO:0042219) | 2.83405351 |
| 141 | rRNA transcription (GO:0009303) | 2.83227312 |
| 142 | de novo posttranslational protein folding (GO:0051084) | 2.82380196 |
| 143 | protein targeting to mitochondrion (GO:0006626) | 2.82146668 |
| 144 | protein localization to mitochondrion (GO:0070585) | 2.82061611 |
| 145 | modulation by symbiont of host cellular process (GO:0044068) | 2.82047668 |
| 146 | nuclear pore complex assembly (GO:0051292) | 2.81840337 |
| 147 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.81433103 |
| 148 | branched-chain amino acid catabolic process (GO:0009083) | 2.81121463 |
| 149 | formation of translation preinitiation complex (GO:0001731) | 2.80973343 |
| 150 | ubiquinone biosynthetic process (GO:0006744) | 2.78714200 |
| 151 | quinone biosynthetic process (GO:1901663) | 2.78714200 |
| 152 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 2.78592831 |
| 153 | negative regulation of ligase activity (GO:0051352) | 2.78592831 |
| 154 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.78564541 |
| 155 | negative regulation of cell size (GO:0045792) | 2.77933505 |
| 156 | base-excision repair (GO:0006284) | 2.75424970 |
| 157 | pantothenate metabolic process (GO:0015939) | 2.75180193 |
| 158 | mitochondrial DNA metabolic process (GO:0032042) | 2.74712463 |
| 159 | GMP metabolic process (GO:0046037) | 2.74630872 |
| 160 | fatty acid homeostasis (GO:0055089) | 2.74129699 |
| 161 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.74078898 |
| 162 | lipopolysaccharide biosynthetic process (GO:0009103) | 2.73969739 |
| 163 | cellular amino acid biosynthetic process (GO:0008652) | 2.73467327 |
| 164 | de novo protein folding (GO:0006458) | 2.71575152 |
| 165 | base-excision repair, AP site formation (GO:0006285) | 2.69403701 |
| 166 | ubiquinone metabolic process (GO:0006743) | 2.69215133 |
| 167 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.67620180 |
| 168 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.67004154 |
| 169 | intracellular estrogen receptor signaling pathway (GO:0030520) | 2.66787451 |
| 170 | negative regulation of RNA splicing (GO:0033119) | 2.66541105 |
| 171 | DNA ligation (GO:0006266) | 2.65087683 |
| 172 | ncRNA 3-end processing (GO:0043628) | 2.64991214 |
| 173 | DNA replication initiation (GO:0006270) | 2.62410799 |
| 174 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.61395712 |
| 175 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.61129099 |
| 176 | guanosine-containing compound biosynthetic process (GO:1901070) | 2.58514728 |
| 177 | peptidyl-arginine modification (GO:0018195) | 2.57607706 |
| 178 | mitotic nuclear envelope disassembly (GO:0007077) | 2.55185730 |
| 179 | vesicle coating (GO:0006901) | 2.54692504 |
| 180 | nuclear pore organization (GO:0006999) | 2.54443915 |
| 181 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.54160890 |
| 182 | regulation of mitochondrial fission (GO:0090140) | 2.53256740 |
| 183 | gluconeogenesis (GO:0006094) | 2.52959592 |
| 184 | pentose-phosphate shunt (GO:0006098) | 2.52951849 |
| 185 | pentose metabolic process (GO:0019321) | 2.50510547 |
| 186 | pyrimidine dimer repair (GO:0006290) | 2.49134724 |
| 187 | pore complex assembly (GO:0046931) | 2.48897067 |
| 188 | nucleobase-containing small molecule interconversion (GO:0015949) | 2.48170135 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.11557188 |
| 2 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 4.10031776 |
| 3 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.99907198 |
| 4 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 3.94860131 |
| 5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 3.89054805 |
| 6 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 3.75706165 |
| 7 | * JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 3.56116058 |
| 8 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 3.36904575 |
| 9 | * ETS1_20019798_ChIP-Seq_JURKAT_Human | 3.34036514 |
| 10 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.28667814 |
| 11 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 3.25676306 |
| 12 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 3.23633266 |
| 13 | * CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.93305061 |
| 14 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.76080959 |
| 15 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.65463337 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.59327477 |
| 17 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.53823235 |
| 18 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.48070009 |
| 19 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 2.40571029 |
| 20 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.35290870 |
| 21 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.33036317 |
| 22 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 2.28555822 |
| 23 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 2.26380170 |
| 24 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 2.26191849 |
| 25 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.25928926 |
| 26 | VDR_23849224_ChIP-Seq_CD4+_Human | 2.20313317 |
| 27 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.19458055 |
| 28 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 2.11896816 |
| 29 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 2.07893133 |
| 30 | GABP_19822575_ChIP-Seq_HepG2_Human | 2.04328161 |
| 31 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.96865247 |
| 32 | * SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.96284051 |
| 33 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.94574251 |
| 34 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.92610691 |
| 35 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.90366384 |
| 36 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.89616530 |
| 37 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.84105319 |
| 38 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.79847672 |
| 39 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.78451126 |
| 40 | MYC_22102868_ChIP-Seq_BL_Human | 1.78220847 |
| 41 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.75473984 |
| 42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.73477610 |
| 43 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.72715358 |
| 44 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.72092576 |
| 45 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.70777136 |
| 46 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.68850213 |
| 47 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.63111439 |
| 48 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.59098364 |
| 49 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.54398073 |
| 50 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.52744233 |
| 51 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.50905607 |
| 52 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.48081076 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.47758184 |
| 54 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.45396411 |
| 55 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.43473350 |
| 56 | * CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.41926162 |
| 57 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40589630 |
| 58 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.40563698 |
| 59 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.38818363 |
| 60 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.37615863 |
| 61 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.36527611 |
| 62 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.36525860 |
| 63 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.35572996 |
| 64 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.34191399 |
| 65 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.32666940 |
| 66 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.31114878 |
| 67 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.29911035 |
| 68 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.28527715 |
| 69 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.27968604 |
| 70 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 1.27334522 |
| 71 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.26283441 |
| 72 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.23398608 |
| 73 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.21831964 |
| 74 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.18875478 |
| 75 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.18061704 |
| 76 | CUX1_19635798_ChIP-ChIP_MULTIPLE_HUMAN_CANCER_TYPES_Human | 1.17780167 |
| 77 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.17508144 |
| 78 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.16607405 |
| 79 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.16430953 |
| 80 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.15925282 |
| 81 | CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.15910321 |
| 82 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.15590240 |
| 83 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.14253031 |
| 84 | GATA1_22025678_ChIP-Seq_K562_Human | 1.14163584 |
| 85 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.13758658 |
| 86 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.13484849 |
| 87 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.12673082 |
| 88 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11675921 |
| 89 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.10813097 |
| 90 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.10735063 |
| 91 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.10599626 |
| 92 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.09796521 |
| 93 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.07617680 |
| 94 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.07182203 |
| 95 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.06053132 |
| 96 | P68_20966046_ChIP-Seq_HELA_Human | 1.05172600 |
| 97 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.04966766 |
| 98 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.04781451 |
| 99 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.04605675 |
| 100 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.04113371 |
| 101 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.04091574 |
| 102 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.03749753 |
| 103 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.03355549 |
| 104 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.02910674 |
| 105 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.01973326 |
| 106 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.01563173 |
| 107 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.00688297 |
| 108 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.00524106 |
| 109 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.00453693 |
| 110 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99576842 |
| 111 | TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.98343493 |
| 112 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.98050710 |
| 113 | MAF_26560356_Chip-Seq_TH2_Human | 0.97159972 |
| 114 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 0.96913017 |
| 115 | E2F7_22180533_ChIP-Seq_HELA_Human | 0.96641874 |
| 116 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.96427732 |
| 117 | TCFCP2L1_18555785_ChIP-Seq_MESCs_Mouse | 0.94409917 |
| 118 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.92313517 |
| 119 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.91696357 |
| 120 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.89387409 |
| 121 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.88866981 |
| 122 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 0.87604356 |
| 123 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 0.87118553 |
| 124 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.86400053 |
| 125 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.85348677 |
| 126 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83530232 |
| 127 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 0.82789700 |
| 128 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.82587501 |
| 129 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.82457857 |
| 130 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.82377034 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 5.89345067 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.63578838 |
| 3 | MP0005360_urolithiasis | 4.34736970 |
| 4 | MP0005085_abnormal_gallbladder_physiolo | 3.98298097 |
| 5 | MP0008058_abnormal_DNA_repair | 3.78898287 |
| 6 | MP0005365_abnormal_bile_salt | 3.72499180 |
| 7 | MP0010094_abnormal_chromosome_stability | 3.70610535 |
| 8 | MP0003111_abnormal_nucleus_morphology | 3.53772876 |
| 9 | MP0008875_abnormal_xenobiotic_pharmacok | 3.46159074 |
| 10 | MP0005451_abnormal_body_composition | 3.06595089 |
| 11 | MP0002877_abnormal_melanocyte_morpholog | 2.99098860 |
| 12 | MP0006036_abnormal_mitochondrial_physio | 2.88489728 |
| 13 | MP0005332_abnormal_amino_acid | 2.76237144 |
| 14 | MP0003077_abnormal_cell_cycle | 2.71909997 |
| 15 | MP0009840_abnormal_foam_cell | 2.64588253 |
| 16 | MP0006035_abnormal_mitochondrial_morpho | 2.45834118 |
| 17 | MP0002837_dystrophic_cardiac_calcinosis | 2.36507767 |
| 18 | MP0008007_abnormal_cellular_replicative | 2.23399216 |
| 19 | MP0003656_abnormal_erythrocyte_physiolo | 2.16143847 |
| 20 | MP0003786_premature_aging | 2.12294312 |
| 21 | MP0003718_maternal_effect | 2.11711071 |
| 22 | MP0000350_abnormal_cell_proliferation | 2.11620563 |
| 23 | MP0010329_abnormal_lipoprotein_level | 2.09045311 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.98884401 |
| 25 | MP0003191_abnormal_cellular_cholesterol | 1.91426878 |
| 26 | MP0005083_abnormal_biliary_tract | 1.86055018 |
| 27 | MP0002822_catalepsy | 1.85185244 |
| 28 | MP0003186_abnormal_redox_activity | 1.83043091 |
| 29 | MP0008057_abnormal_DNA_replication | 1.81584059 |
| 30 | MP0005377_hearing/vestibular/ear_phenot | 1.79332217 |
| 31 | MP0003878_abnormal_ear_physiology | 1.79332217 |
| 32 | MP0004957_abnormal_blastocyst_morpholog | 1.75615986 |
| 33 | MP0003195_calcinosis | 1.75410774 |
| 34 | MP0004264_abnormal_extraembryonic_tissu | 1.75408154 |
| 35 | MP0001764_abnormal_homeostasis | 1.71690351 |
| 36 | MP0003763_abnormal_thymus_physiology | 1.63353416 |
| 37 | MP0004147_increased_porphyrin_level | 1.62988495 |
| 38 | MP0003567_abnormal_fetal_cardiomyocyte | 1.56610380 |
| 39 | MP0005319_abnormal_enzyme/_coenzyme | 1.55166995 |
| 40 | MP0002080_prenatal_lethality | 1.55093512 |
| 41 | MP0005380_embryogenesis_phenotype | 1.48907547 |
| 42 | MP0001672_abnormal_embryogenesis/_devel | 1.48907547 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.48206672 |
| 44 | MP0000313_abnormal_cell_death | 1.45839010 |
| 45 | MP0003646_muscle_fatigue | 1.45643595 |
| 46 | MP0003252_abnormal_bile_duct | 1.45401444 |
| 47 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.45315144 |
| 48 | MP0003880_abnormal_central_pattern | 1.44284333 |
| 49 | MP0004185_abnormal_adipocyte_glucose | 1.42379675 |
| 50 | MP0001905_abnormal_dopamine_level | 1.41670137 |
| 51 | MP0003329_amyloid_beta_deposits | 1.40875712 |
| 52 | MP0003984_embryonic_growth_retardation | 1.39917827 |
| 53 | MP0002736_abnormal_nociception_after | 1.39043657 |
| 54 | MP0002064_seizures | 1.38838380 |
| 55 | MP0005501_abnormal_skin_physiology | 1.38319655 |
| 56 | MP0002396_abnormal_hematopoietic_system | 1.37152366 |
| 57 | MP0001529_abnormal_vocalization | 1.35368501 |
| 58 | MP0005384_cellular_phenotype | 1.31471491 |
| 59 | MP0000013_abnormal_adipose_tissue | 1.30351014 |
| 60 | MP0001697_abnormal_embryo_size | 1.30140263 |
| 61 | MP0005636_abnormal_mineral_homeostasis | 1.29672740 |
| 62 | MP0002118_abnormal_lipid_homeostasis | 1.28891898 |
| 63 | MP0005266_abnormal_metabolism | 1.26870062 |
| 64 | MP0000609_abnormal_liver_physiology | 1.26842328 |
| 65 | MP0009046_muscle_twitch | 1.26776514 |
| 66 | MP0002088_abnormal_embryonic_growth/wei | 1.26034534 |
| 67 | MP0004859_abnormal_synaptic_plasticity | 1.25779631 |
| 68 | MP0001968_abnormal_touch/_nociception | 1.25583099 |
| 69 | MP0002019_abnormal_tumor_incidence | 1.25458889 |
| 70 | MP0005621_abnormal_cell_physiology | 1.25356698 |
| 71 | MP0002269_muscular_atrophy | 1.25034541 |
| 72 | MP0008260_abnormal_autophagy | 1.24247695 |
| 73 | MP0005670_abnormal_white_adipose | 1.22367473 |
| 74 | MP0009643_abnormal_urine_homeostasis | 1.22148861 |
| 75 | MP0001756_abnormal_urination | 1.21721590 |
| 76 | MP0003172_abnormal_lysosome_physiology | 1.18117838 |
| 77 | MP0005058_abnormal_lysosome_morphology | 1.17150266 |
| 78 | MP0009745_abnormal_behavioral_response | 1.16549348 |
| 79 | MP0005084_abnormal_gallbladder_morpholo | 1.15059832 |
| 80 | MP0001727_abnormal_embryo_implantation | 1.14608375 |
| 81 | MP0004233_abnormal_muscle_weight | 1.13886654 |
| 82 | MP0004036_abnormal_muscle_relaxation | 1.13779318 |
| 83 | MP0003635_abnormal_synaptic_transmissio | 1.13590023 |
| 84 | MP0005330_cardiomyopathy | 1.13162068 |
| 85 | MP0002160_abnormal_reproductive_system | 1.12638847 |
| 86 | MP0000604_amyloidosis | 1.12381362 |
| 87 | MP0009672_abnormal_birth_weight | 1.11876812 |
| 88 | MP0002876_abnormal_thyroid_physiology | 1.11224616 |
| 89 | MP0001661_extended_life_span | 1.10086424 |
| 90 | MP0000703_abnormal_thymus_morphology | 1.09441923 |
| 91 | MP0000747_muscle_weakness | 1.09291875 |
| 92 | MP0004084_abnormal_cardiac_muscle | 1.08115239 |
| 93 | MP0004019_abnormal_vitamin_homeostasis | 1.07627381 |
| 94 | MP0000358_abnormal_cell_content/ | 1.05201858 |
| 95 | MP0004215_abnormal_myocardial_fiber | 1.04102851 |
| 96 | MP0009697_abnormal_copulation | 1.04041339 |
| 97 | MP0000751_myopathy | 1.03898549 |
| 98 | MP0004197_abnormal_fetal_growth/weight/ | 1.03891170 |
| 99 | MP0005535_abnormal_body_temperature | 1.02098735 |
| 100 | MP0002127_abnormal_cardiovascular_syste | 1.01255350 |
| 101 | MP0001984_abnormal_olfaction | 1.00965523 |
| 102 | MP0010234_abnormal_vibrissa_follicle | 0.99682446 |
| 103 | MP0002009_preneoplasia | 0.99242415 |
| 104 | MP0004130_abnormal_muscle_cell | 0.99038838 |
| 105 | MP0000681_abnormal_thyroid_gland | 0.98458520 |
| 106 | MP0004142_abnormal_muscle_tone | 0.98367268 |
| 107 | MP0001542_abnormal_bone_strength | 0.97405292 |
| 108 | MP0000858_altered_metastatic_potential | 0.96978144 |
| 109 | MP0008872_abnormal_physiological_respon | 0.96624490 |
| 110 | MP0002086_abnormal_extraembryonic_tissu | 0.96224160 |
| 111 | MP0001188_hyperpigmentation | 0.96087369 |
| 112 | MP0004782_abnormal_surfactant_physiolog | 0.95589055 |
| 113 | MP0002272_abnormal_nervous_system | 0.94547614 |
| 114 | MP0005075_abnormal_melanosome_morpholog | 0.94409044 |
| 115 | MP0008995_early_reproductive_senescence | 0.93272467 |
| 116 | MP0005666_abnormal_adipose_tissue | 0.92766011 |
| 117 | MP0005376_homeostasis/metabolism_phenot | 0.90311335 |
| 118 | MP0000678_abnormal_parathyroid_gland | 0.89542321 |
| 119 | MP0002970_abnormal_white_adipose | 0.89419130 |
| 120 | MP0009333_abnormal_splenocyte_physiolog | 0.89402524 |
| 121 | MP0001485_abnormal_pinna_reflex | 0.88020891 |
| 122 | MP0000759_abnormal_skeletal_muscle | 0.84998583 |
| 123 | MP0001270_distended_abdomen | 0.84786809 |
| 124 | MP0000598_abnormal_liver_morphology | 0.84384642 |
| 125 | MP0003221_abnormal_cardiomyocyte_apopto | 0.84176071 |
| 126 | MP0003115_abnormal_respiratory_system | 0.83346940 |
| 127 | MP0000733_abnormal_muscle_development | 0.82724481 |
| 128 | MP0002332_abnormal_exercise_endurance | 0.82602867 |
| 129 | MP0001730_embryonic_growth_arrest | 0.79711999 |
| 130 | MP0002735_abnormal_chemical_nociception | 0.79666928 |
| 131 | MP0003315_abnormal_perineum_morphology | 0.79277006 |
| 132 | MP0005395_other_phenotype | 0.78363925 |
| 133 | MP0006276_abnormal_autonomic_nervous | 0.77504314 |
| 134 | MP0002722_abnormal_immune_system | 0.77340843 |
| 135 | MP0000749_muscle_degeneration | 0.77150014 |
| 136 | MP0004145_abnormal_muscle_electrophysio | 0.76360790 |
| 137 | MP0000639_abnormal_adrenal_gland | 0.75918377 |
| 138 | MP0008874_decreased_physiological_sensi | 0.75427290 |
| 139 | MP0004858_abnormal_nervous_system | 0.75249832 |
| 140 | MP0004043_abnormal_pH_regulation | 0.74986351 |
| 141 | MP0008932_abnormal_embryonic_tissue | 0.74976642 |
| 142 | MP0002084_abnormal_developmental_patter | 0.74630295 |
| 143 | MP0000537_abnormal_urethra_morphology | 0.73842982 |
| 144 | MP0004270_analgesia | 0.72283403 |
| 145 | MP0002063_abnormal_learning/memory/cond | 0.71927953 |
| 146 | MP0002572_abnormal_emotion/affect_behav | 0.71308399 |
| 147 | MP0000490_abnormal_crypts_of | 0.70996261 |
| 148 | MP0002085_abnormal_embryonic_tissue | 0.70739620 |
| 149 | MP0003638_abnormal_response/metabolism_ | 0.70646449 |
| 150 | MP0001915_intracranial_hemorrhage | 0.70495529 |
| 151 | MP0003385_abnormal_body_wall | 0.70471438 |
| 152 | MP0005623_abnormal_meninges_morphology | 0.70400857 |
| 153 | MP0002075_abnormal_coat/hair_pigmentati | 0.70041478 |
| 154 | MP0005187_abnormal_penis_morphology | 0.69998154 |
| 155 | MP0005389_reproductive_system_phenotype | 0.69613238 |
| 156 | MP0000750_abnormal_muscle_regeneration | 0.69202906 |
| 157 | MP0004087_abnormal_muscle_fiber | 0.67134361 |
| 158 | MP0005408_hypopigmentation | 0.65265669 |
| 159 | MP0002078_abnormal_glucose_homeostasis | 0.64644858 |
| 160 | MP0003943_abnormal_hepatobiliary_system | 0.62634831 |
| 161 | MP0000003_abnormal_adipose_tissue | 0.62629462 |
| 162 | MP0000689_abnormal_spleen_morphology | 0.61477215 |
| 163 | MP0001853_heart_inflammation | 0.59998375 |
| 164 | MP0002796_impaired_skin_barrier | 0.59371136 |
| 165 | MP0002098_abnormal_vibrissa_morphology | 0.57355855 |
| 166 | MP0010630_abnormal_cardiac_muscle | 0.57223769 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased serum pyruvate (HP:0003542) | 4.41180470 |
| 2 | Abnormality of glycolysis (HP:0004366) | 4.41180470 |
| 3 | Hepatocellular necrosis (HP:0001404) | 4.35509971 |
| 4 | Hyperglycinemia (HP:0002154) | 4.10119236 |
| 5 | Hepatic necrosis (HP:0002605) | 4.02775252 |
| 6 | Abnormal mitochondria in muscle tissue (HP:0008316) | 4.00399444 |
| 7 | Acute necrotizing encephalopathy (HP:0006965) | 3.91792091 |
| 8 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.86494136 |
| 9 | Microvesicular hepatic steatosis (HP:0001414) | 3.86457701 |
| 10 | Acute encephalopathy (HP:0006846) | 3.85267695 |
| 11 | Cerebral edema (HP:0002181) | 3.80848211 |
| 12 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 3.66720329 |
| 13 | Abnormality of alanine metabolism (HP:0010916) | 3.66720329 |
| 14 | Hyperalaninemia (HP:0003348) | 3.66720329 |
| 15 | Hyperglycinuria (HP:0003108) | 3.61916628 |
| 16 | Mitochondrial inheritance (HP:0001427) | 3.59030781 |
| 17 | Hypobetalipoproteinemia (HP:0003563) | 3.57504265 |
| 18 | Increased CSF lactate (HP:0002490) | 3.57503837 |
| 19 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 3.54318903 |
| 20 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 3.54318903 |
| 21 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.53897065 |
| 22 | Abnormality of glycine metabolism (HP:0010895) | 3.53897065 |
| 23 | Multiple enchondromatosis (HP:0005701) | 3.50664874 |
| 24 | Lactic acidosis (HP:0003128) | 3.44493679 |
| 25 | Gout (HP:0001997) | 3.32365185 |
| 26 | Progressive macrocephaly (HP:0004481) | 3.28227233 |
| 27 | Abnormality of serum amino acid levels (HP:0003112) | 3.24340800 |
| 28 | CNS demyelination (HP:0007305) | 3.19667079 |
| 29 | Shoulder girdle muscle weakness (HP:0003547) | 3.09971444 |
| 30 | Ragged-red muscle fibers (HP:0003200) | 3.06250656 |
| 31 | Lethargy (HP:0001254) | 3.04445775 |
| 32 | Increased serum lactate (HP:0002151) | 3.01331396 |
| 33 | Hyperammonemia (HP:0001987) | 3.00261880 |
| 34 | Methylmalonic aciduria (HP:0012120) | 2.84470412 |
| 35 | Upper motor neuron abnormality (HP:0002127) | 2.82323895 |
| 36 | Respiratory failure (HP:0002878) | 2.81523464 |
| 37 | Ependymoma (HP:0002888) | 2.80842457 |
| 38 | Intrahepatic cholestasis (HP:0001406) | 2.78546705 |
| 39 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.77363157 |
| 40 | Progressive muscle weakness (HP:0003323) | 2.76339395 |
| 41 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.76094059 |
| 42 | Delusions (HP:0000746) | 2.72809106 |
| 43 | Cutaneous melanoma (HP:0012056) | 2.72720049 |
| 44 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.72360560 |
| 45 | Deep venous thrombosis (HP:0002625) | 2.70616107 |
| 46 | Abnormal neuron morphology (HP:0012757) | 2.66147237 |
| 47 | Abnormality of the motor neurons (HP:0002450) | 2.66147237 |
| 48 | Hyperlipoproteinemia (HP:0010980) | 2.65584901 |
| 49 | Opisthotonus (HP:0002179) | 2.63783726 |
| 50 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.60975934 |
| 51 | Dicarboxylic aciduria (HP:0003215) | 2.60975934 |
| 52 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.59323041 |
| 53 | Xanthomatosis (HP:0000991) | 2.58419971 |
| 54 | Ketosis (HP:0001946) | 2.57690546 |
| 55 | Prolonged partial thromboplastin time (HP:0003645) | 2.57453415 |
| 56 | Abnormal gallbladder physiology (HP:0012438) | 2.56043636 |
| 57 | Cholecystitis (HP:0001082) | 2.56043636 |
| 58 | Reticulocytosis (HP:0001923) | 2.55766209 |
| 59 | Hypolipoproteinemia (HP:0010981) | 2.54083442 |
| 60 | Increased intramyocellular lipid droplets (HP:0012240) | 2.53312213 |
| 61 | CNS hypomyelination (HP:0003429) | 2.52494937 |
| 62 | Progressive external ophthalmoplegia (HP:0000590) | 2.51961870 |
| 63 | Truncus arteriosus (HP:0001660) | 2.51286355 |
| 64 | Pelvic girdle muscle weakness (HP:0003749) | 2.50811379 |
| 65 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50042627 |
| 66 | Emotional lability (HP:0000712) | 2.48702738 |
| 67 | Cerebral hypomyelination (HP:0006808) | 2.47444811 |
| 68 | Back pain (HP:0003418) | 2.47028839 |
| 69 | Increased muscle lipid content (HP:0009058) | 2.46499162 |
| 70 | Delayed CNS myelination (HP:0002188) | 2.42510148 |
| 71 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.41706187 |
| 72 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.41706187 |
| 73 | Abnormal protein glycosylation (HP:0012346) | 2.41706187 |
| 74 | Abnormal glycosylation (HP:0012345) | 2.41706187 |
| 75 | Astrocytoma (HP:0009592) | 2.41614402 |
| 76 | Abnormality of the astrocytes (HP:0100707) | 2.41614402 |
| 77 | Myoglobinuria (HP:0002913) | 2.40306593 |
| 78 | Hyperacusis (HP:0010780) | 2.38483930 |
| 79 | Methylmalonic acidemia (HP:0002912) | 2.37378623 |
| 80 | Type I transferrin isoform profile (HP:0003642) | 2.36884280 |
| 81 | Spastic diplegia (HP:0001264) | 2.36809075 |
| 82 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.33750151 |
| 83 | Alacrima (HP:0000522) | 2.33670322 |
| 84 | Vertebral compression fractures (HP:0002953) | 2.31989924 |
| 85 | J-shaped sella turcica (HP:0002680) | 2.31989116 |
| 86 | Hyperventilation (HP:0002883) | 2.30897926 |
| 87 | Unsteady gait (HP:0002317) | 2.29313923 |
| 88 | Insomnia (HP:0100785) | 2.28608470 |
| 89 | Exercise intolerance (HP:0003546) | 2.26680154 |
| 90 | Abnormality of methionine metabolism (HP:0010901) | 2.24946824 |
| 91 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.24437575 |
| 92 | Squamous cell carcinoma (HP:0002860) | 2.23060467 |
| 93 | Testicular atrophy (HP:0000029) | 2.22841746 |
| 94 | Rhabdomyolysis (HP:0003201) | 2.22576748 |
| 95 | Breast hypoplasia (HP:0003187) | 2.19015210 |
| 96 | Vomiting (HP:0002013) | 2.18189458 |
| 97 | Amyotrophic lateral sclerosis (HP:0007354) | 2.17425408 |
| 98 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.15671455 |
| 99 | Metabolic acidosis (HP:0001942) | 2.15437497 |
| 100 | Hand muscle atrophy (HP:0009130) | 2.13626642 |
| 101 | Abnormality of the lower motor neuron (HP:0002366) | 2.09716507 |
| 102 | Secondary amenorrhea (HP:0000869) | 2.06005835 |
| 103 | Abnormal cartilage morphology (HP:0002763) | 2.05346216 |
| 104 | Abnormality of the musculature of the pelvis (HP:0001469) | 2.04701475 |
| 105 | Abnormality of the hip-girdle musculature (HP:0001445) | 2.04701475 |
| 106 | Orthostatic hypotension (HP:0001278) | 2.04528885 |
| 107 | Leukodystrophy (HP:0002415) | 2.04213237 |
| 108 | Growth hormone excess (HP:0000845) | 2.03541107 |
| 109 | Distal upper limb amyotrophy (HP:0007149) | 2.01364918 |
| 110 | Upper limb amyotrophy (HP:0009129) | 2.01364918 |
| 111 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 2.00689652 |
| 112 | Focal motor seizures (HP:0011153) | 2.00186616 |
| 113 | Proximal placement of thumb (HP:0009623) | 1.99837944 |
| 114 | Entropion (HP:0000621) | 1.99693059 |
| 115 | Degeneration of anterior horn cells (HP:0002398) | 1.99379559 |
| 116 | Abnormality of the anterior horn cell (HP:0006802) | 1.99379559 |
| 117 | Hypokinesia (HP:0002375) | 1.98695396 |
| 118 | Reduced antithrombin III activity (HP:0001976) | 1.98341875 |
| 119 | Cortical dysplasia (HP:0002539) | 1.97362606 |
| 120 | Increased purine levels (HP:0004368) | 1.97318579 |
| 121 | Hyperuricemia (HP:0002149) | 1.97318579 |
| 122 | Exercise-induced myalgia (HP:0003738) | 1.97277958 |
| 123 | Decreased number of large peripheral myelinated nerve fibers (HP:0003387) | 1.96511932 |
| 124 | Scanning speech (HP:0002168) | 1.96417220 |
| 125 | Abnormality of oral frenula (HP:0000190) | 1.96029733 |
| 126 | Seborrheic dermatitis (HP:0001051) | 1.95015835 |
| 127 | Spastic paraparesis (HP:0002313) | 1.94890608 |
| 128 | Hypoalphalipoproteinemia (HP:0003233) | 1.94718543 |
| 129 | Ketoacidosis (HP:0001993) | 1.94323928 |
| 130 | Brushfield spots (HP:0001088) | 1.93746467 |
| 131 | Cholelithiasis (HP:0001081) | 1.93349413 |
| 132 | Progressive microcephaly (HP:0000253) | 1.91595338 |
| 133 | Neuroendocrine neoplasm (HP:0100634) | 1.90589800 |
| 134 | Muscle abnormality related to mitochondrial dysfunction (HP:0003800) | 1.90230532 |
| 135 | Selective tooth agenesis (HP:0001592) | 1.89557402 |
| 136 | Lipid accumulation in hepatocytes (HP:0006561) | 1.88659821 |
| 137 | Abnormal gallbladder morphology (HP:0012437) | 1.87877559 |
| 138 | Palpitations (HP:0001962) | 1.86606704 |
| 139 | Birth length less than 3rd percentile (HP:0003561) | 1.85875765 |
| 140 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.84607238 |
| 141 | Complement deficiency (HP:0004431) | 1.84025580 |
| 142 | Long clavicles (HP:0000890) | 1.83834194 |
| 143 | Atonic seizures (HP:0010819) | 1.83831076 |
| 144 | Gliosis (HP:0002171) | 1.83781746 |
| 145 | Generalized aminoaciduria (HP:0002909) | 1.82798919 |
| 146 | Abnormality of purine metabolism (HP:0004352) | 1.82778066 |
| 147 | Irritability (HP:0000737) | 1.82570794 |
| 148 | Postnatal microcephaly (HP:0005484) | 1.81206971 |
| 149 | Limb-girdle muscle atrophy (HP:0003797) | 1.81081259 |
| 150 | Increased hepatocellular lipid droplets (HP:0006565) | 1.80604372 |
| 151 | Macrocytic anemia (HP:0001972) | 1.80511886 |
| 152 | Decreased lacrimation (HP:0000633) | 1.77338296 |
| 153 | Abnormality of the distal phalanges of the toes (HP:0010182) | 1.77261239 |
| 154 | Abnormality of the gallbladder (HP:0005264) | 1.77258976 |
| 155 | Global brain atrophy (HP:0002283) | 1.77162081 |
| 156 | Abnormal number of erythroid precursors (HP:0012131) | 1.77047544 |
| 157 | Fat malabsorption (HP:0002630) | 1.76966686 |
| 158 | Peripheral hypomyelination (HP:0007182) | 1.74644992 |
| 159 | Epiphyseal stippling (HP:0010655) | 1.73740794 |
| 160 | Deviation of the thumb (HP:0009603) | 1.73571446 |
| 161 | Microretrognathia (HP:0000308) | 1.73217673 |
| 162 | Upper limb muscle weakness (HP:0003484) | 1.72488319 |
| 163 | Basal cell carcinoma (HP:0002671) | 1.70924199 |
| 164 | Glioma (HP:0009733) | 1.69156533 |
| 165 | Myopathic facies (HP:0002058) | 1.69130408 |
| 166 | Prolonged neonatal jaundice (HP:0006579) | 1.68189996 |
| 167 | Acute hepatic failure (HP:0006554) | 1.66600223 |
| 168 | Flat acetabular roof (HP:0003180) | 1.65508068 |
| 169 | Death in infancy (HP:0001522) | 1.64963894 |
| 170 | Medulloblastoma (HP:0002885) | 1.64228342 |
| 171 | High anterior hairline (HP:0009890) | 1.62763022 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ARAF | 6.44898336 |
| 2 | RIPK1 | 4.00262556 |
| 3 | PIM2 | 3.48684217 |
| 4 | BCKDK | 3.42107313 |
| 5 | BRAF | 3.36025114 |
| 6 | TSSK6 | 3.08203502 |
| 7 | TESK1 | 2.93363743 |
| 8 | WEE1 | 2.70896942 |
| 9 | BUB1 | 2.64160225 |
| 10 | MAP3K11 | 2.42386556 |
| 11 | EIF2AK1 | 2.25578526 |
| 12 | TAOK2 | 2.21745521 |
| 13 | AKT3 | 2.14882791 |
| 14 | MAP3K12 | 2.13249251 |
| 15 | STK16 | 2.06476023 |
| 16 | SMG1 | 2.01282213 |
| 17 | NEK1 | 1.99162482 |
| 18 | PBK | 1.98543162 |
| 19 | RAF1 | 1.96451002 |
| 20 | KDR | 1.93146886 |
| 21 | PDK3 | 1.87412757 |
| 22 | PDK4 | 1.87412757 |
| 23 | CCNB1 | 1.84881391 |
| 24 | RPS6KA4 | 1.83142574 |
| 25 | VRK2 | 1.78058081 |
| 26 | MAP2K3 | 1.76371393 |
| 27 | NME2 | 1.71317634 |
| 28 | TESK2 | 1.67016784 |
| 29 | CASK | 1.62282244 |
| 30 | EEF2K | 1.52300811 |
| 31 | CDK19 | 1.49389899 |
| 32 | PDK2 | 1.48688961 |
| 33 | PLK3 | 1.47246731 |
| 34 | IRAK3 | 1.42434476 |
| 35 | ICK | 1.39261681 |
| 36 | ERN1 | 1.30879349 |
| 37 | TAOK1 | 1.30825562 |
| 38 | NME1 | 1.30674261 |
| 39 | MAP2K4 | 1.29956044 |
| 40 | PAK4 | 1.27525143 |
| 41 | BRSK2 | 1.25017665 |
| 42 | PAK6 | 1.24572451 |
| 43 | TTK | 1.23669521 |
| 44 | CDK6 | 1.21127949 |
| 45 | ATR | 1.18839597 |
| 46 | CAMKK2 | 1.18437037 |
| 47 | CDK12 | 1.17269547 |
| 48 | GRK5 | 1.15574416 |
| 49 | EPHA2 | 1.15525450 |
| 50 | PLK2 | 1.15300284 |
| 51 | TRIM28 | 1.15055884 |
| 52 | NEK6 | 1.07382665 |
| 53 | PRPF4B | 1.06567818 |
| 54 | CDK7 | 1.01173748 |
| 55 | BCR | 1.00812989 |
| 56 | DYRK1B | 1.00300269 |
| 57 | CSNK1G3 | 0.96488411 |
| 58 | MINK1 | 0.96486701 |
| 59 | GRK6 | 0.96124011 |
| 60 | PINK1 | 0.95726259 |
| 61 | FGFR4 | 0.95206002 |
| 62 | ERBB3 | 0.95169902 |
| 63 | OXSR1 | 0.94483592 |
| 64 | MAP4K2 | 0.91502574 |
| 65 | CDK4 | 0.90931353 |
| 66 | PNCK | 0.86731173 |
| 67 | CDC7 | 0.86670897 |
| 68 | MAPK11 | 0.84303090 |
| 69 | MAP3K6 | 0.83605670 |
| 70 | MAP3K10 | 0.83188930 |
| 71 | MAP3K3 | 0.81916049 |
| 72 | CAMK2G | 0.81847176 |
| 73 | EPHA4 | 0.80547275 |
| 74 | VRK1 | 0.80443864 |
| 75 | BMPR1B | 0.80246855 |
| 76 | IRAK2 | 0.78822548 |
| 77 | MYLK | 0.76393728 |
| 78 | DAPK1 | 0.75857049 |
| 79 | BRSK1 | 0.73492200 |
| 80 | PLK1 | 0.72621891 |
| 81 | AURKA | 0.71742833 |
| 82 | TLK1 | 0.70652059 |
| 83 | CHEK1 | 0.70610561 |
| 84 | MAP3K5 | 0.69569064 |
| 85 | DAPK3 | 0.67115926 |
| 86 | PRKCI | 0.66957000 |
| 87 | CDK8 | 0.66889979 |
| 88 | MAP2K7 | 0.65648194 |
| 89 | CSNK1G2 | 0.63305286 |
| 90 | NTRK3 | 0.60437138 |
| 91 | RET | 0.59488550 |
| 92 | WNK3 | 0.58413277 |
| 93 | AKT2 | 0.57510863 |
| 94 | TBK1 | 0.57348869 |
| 95 | LIMK1 | 0.54645979 |
| 96 | CHEK2 | 0.53964688 |
| 97 | CLK1 | 0.53800961 |
| 98 | KSR2 | 0.53700823 |
| 99 | PRKCG | 0.52671152 |
| 100 | EIF2AK2 | 0.52121436 |
| 101 | CDK11A | 0.50846980 |
| 102 | ERBB4 | 0.50318011 |
| 103 | CDK18 | 0.47890126 |
| 104 | AURKB | 0.47058141 |
| 105 | CDK2 | 0.46904787 |
| 106 | OBSCN | 0.46718355 |
| 107 | CDK15 | 0.45377482 |
| 108 | MAP3K4 | 0.45119331 |
| 109 | RPS6KB2 | 0.43459973 |
| 110 | CSNK1A1L | 0.42850953 |
| 111 | CSNK1G1 | 0.42642120 |
| 112 | CAMKK1 | 0.42034110 |
| 113 | CAMK2B | 0.40507164 |
| 114 | PDPK1 | 0.40257215 |
| 115 | KSR1 | 0.39854592 |
| 116 | PTK2B | 0.39388904 |
| 117 | FLT3 | 0.39228928 |
| 118 | PASK | 0.38999462 |
| 119 | ZAP70 | 0.38029025 |
| 120 | ABL2 | 0.37182426 |
| 121 | MAP3K8 | 0.37090607 |
| 122 | MAPKAPK3 | 0.36143026 |
| 123 | CDK1 | 0.35939752 |
| 124 | MUSK | 0.35580180 |
| 125 | PAK1 | 0.35235123 |
| 126 | MATK | 0.34938386 |
| 127 | MAP2K2 | 0.34919721 |
| 128 | LRRK2 | 0.34569013 |
| 129 | FGR | 0.33904686 |
| 130 | PRKD3 | 0.33358015 |
| 131 | ATM | 0.32820801 |
| 132 | MAP3K14 | 0.32730274 |
| 133 | DAPK2 | 0.31782417 |
| 134 | PKN2 | 0.31284828 |
| 135 | SCYL2 | 0.31039660 |
| 136 | ILK | 0.30666045 |
| 137 | MAP2K1 | 0.30075302 |
| 138 | NEK9 | 0.29590657 |
| 139 | STK24 | 0.29230633 |
| 140 | PDK1 | 0.29077702 |
| 141 | RIPK4 | 0.27702622 |
| 142 | RPS6KA5 | 0.26320752 |
| 143 | MOS | 0.23454986 |
| 144 | CDK14 | 0.22149601 |
| 145 | EIF2AK3 | 0.21444643 |
| 146 | ZAK | 0.20998992 |
| 147 | TRIB3 | 0.19149003 |
| 148 | CSNK2A1 | 0.18939256 |
| 149 | SRPK1 | 0.18475908 |
| 150 | CSNK2A2 | 0.18235012 |
| 151 | ACVR1B | 0.17916983 |
| 152 | ADRBK1 | 0.17082431 |
| 153 | TYRO3 | 0.16483713 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.63451175 |
| 2 | Proteasome_Homo sapiens_hsa03050 | 3.24579773 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.11631665 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 3.08586375 |
| 5 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.06787805 |
| 6 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.64051653 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.56087791 |
| 8 | RNA polymerase_Homo sapiens_hsa03020 | 2.50585244 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.34407500 |
| 10 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.27865672 |
| 11 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 2.14315783 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 2.13084422 |
| 13 | Parkinsons disease_Homo sapiens_hsa05012 | 2.12603173 |
| 14 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.12195652 |
| 15 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.08636880 |
| 16 | Carbon metabolism_Homo sapiens_hsa01200 | 2.02957521 |
| 17 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 2.00938004 |
| 18 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.00063732 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.98767751 |
| 20 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.90265332 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.76096761 |
| 22 | Ribosome_Homo sapiens_hsa03010 | 1.63243928 |
| 23 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.63127408 |
| 24 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.61175397 |
| 25 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.57948830 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.56992436 |
| 27 | Alzheimers disease_Homo sapiens_hsa05010 | 1.48753188 |
| 28 | Huntingtons disease_Homo sapiens_hsa05016 | 1.45653184 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.45091440 |
| 30 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.42916728 |
| 31 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.40355323 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.34847275 |
| 33 | Peroxisome_Homo sapiens_hsa04146 | 1.34634162 |
| 34 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.33572266 |
| 35 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.31551653 |
| 36 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.31130226 |
| 37 | Other glycan degradation_Homo sapiens_hsa00511 | 1.30050770 |
| 38 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.29368984 |
| 39 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.28592644 |
| 40 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.25440708 |
| 41 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 1.24315660 |
| 42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.23000657 |
| 43 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.21079713 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.17198899 |
| 45 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.15917614 |
| 46 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.14529530 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.09418863 |
| 48 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.09024696 |
| 49 | Cell cycle_Homo sapiens_hsa04110 | 1.07088565 |
| 50 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.06848318 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.05854557 |
| 52 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.05463421 |
| 53 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.03421400 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02975991 |
| 55 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.02208743 |
| 56 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 1.00744884 |
| 57 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.00536640 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.99474481 |
| 59 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.98284080 |
| 60 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.97657545 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.96195328 |
| 62 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.93659872 |
| 63 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.92908434 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.92267999 |
| 65 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.90535405 |
| 66 | DNA replication_Homo sapiens_hsa03030 | 0.89651449 |
| 67 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.89228210 |
| 68 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.87499987 |
| 69 | Shigellosis_Homo sapiens_hsa05131 | 0.83715775 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82892414 |
| 71 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.82499638 |
| 72 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78836037 |
| 73 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.77411636 |
| 74 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.77382456 |
| 75 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.76844264 |
| 76 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.76479456 |
| 77 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.75672701 |
| 78 | Metabolic pathways_Homo sapiens_hsa01100 | 0.75206063 |
| 79 | GABAergic synapse_Homo sapiens_hsa04727 | 0.74186285 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.72140737 |
| 81 | Purine metabolism_Homo sapiens_hsa00230 | 0.70721747 |
| 82 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.69409243 |
| 83 | Sulfur relay system_Homo sapiens_hsa04122 | 0.68364780 |
| 84 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.68061960 |
| 85 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.67910846 |
| 86 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.67521421 |
| 87 | Lysine degradation_Homo sapiens_hsa00310 | 0.67411145 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.65885934 |
| 89 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.65688233 |
| 90 | RNA transport_Homo sapiens_hsa03013 | 0.64472743 |
| 91 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.64444747 |
| 92 | Homologous recombination_Homo sapiens_hsa03440 | 0.64072265 |
| 93 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.62859782 |
| 94 | Thyroid cancer_Homo sapiens_hsa05216 | 0.59787959 |
| 95 | Histidine metabolism_Homo sapiens_hsa00340 | 0.58713916 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.57509687 |
| 97 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.56740083 |
| 98 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.55142091 |
| 99 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.54879071 |
| 100 | Protein export_Homo sapiens_hsa03060 | 0.53890474 |
| 101 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.50950548 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50936940 |
| 103 | Base excision repair_Homo sapiens_hsa03410 | 0.50880590 |
| 104 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.50607258 |
| 105 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.48037112 |
| 106 | Olfactory transduction_Homo sapiens_hsa04740 | 0.47280244 |
| 107 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.46765108 |
| 108 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.45247658 |
| 109 | Mismatch repair_Homo sapiens_hsa03430 | 0.44890404 |
| 110 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44802088 |
| 111 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.41525888 |
| 112 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.40988124 |
| 113 | Colorectal cancer_Homo sapiens_hsa05210 | 0.39473972 |
| 114 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.39404310 |
| 115 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.38820546 |
| 116 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.38790057 |
| 117 | Endometrial cancer_Homo sapiens_hsa05213 | 0.38285669 |
| 118 | Bladder cancer_Homo sapiens_hsa05219 | 0.37783901 |
| 119 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.37430504 |
| 120 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.37426749 |
| 121 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.36212011 |
| 122 | Bile secretion_Homo sapiens_hsa04976 | 0.33749294 |
| 123 | Lysosome_Homo sapiens_hsa04142 | 0.33443682 |
| 124 | Salmonella infection_Homo sapiens_hsa05132 | 0.32676624 |
| 125 | Retinol metabolism_Homo sapiens_hsa00830 | 0.32490342 |
| 126 | Morphine addiction_Homo sapiens_hsa05032 | 0.32388945 |
| 127 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.32158861 |
| 128 | Apoptosis_Homo sapiens_hsa04210 | 0.31641452 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.29744487 |
| 130 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.28176115 |
| 131 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.27670646 |
| 132 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.26840964 |
| 133 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.25798037 |
| 134 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.25647828 |
| 135 | Nicotine addiction_Homo sapiens_hsa05033 | 0.25463001 |
| 136 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.24395306 |
| 137 | Prion diseases_Homo sapiens_hsa05020 | 0.24067817 |
| 138 | Galactose metabolism_Homo sapiens_hsa00052 | 0.23837630 |
| 139 | RNA degradation_Homo sapiens_hsa03018 | 0.22233074 |
| 140 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.21634052 |
| 141 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.21621775 |
| 142 | Circadian entrainment_Homo sapiens_hsa04713 | 0.21570390 |

